tiprankstipranks
Trending News
More News >
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
US Market

BridgeBio Oncology Therapeutics (BBOT) Income Statement

Compare
42 Followers

BridgeBio Oncology Therapeutics Income Statement

Last quarter (Q4 2025), BridgeBio Oncology Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, BridgeBio Oncology Therapeutics's net income was $-38.80M. See BridgeBio Oncology Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -610.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 145.82M$ 80.86M$ 64.77M$ 3.52K$ 43.36K
Depreciation and Amortization
$ 0.00$ 208.00K$ 92.00K$ 0.00$ 0.00
EBITDA
$ -145.82M$ -80.66M$ -64.68M$ -3.52K$ -43.36K
Operating Income
$ -145.82M$ -80.86M$ -64.77M$ -3.52K$ -43.36K
Other Income/Expenses
$ 11.78M$ 8.18M$ 72.00K$ 0.00$ 0.00
Pretax Income
$ -134.04M$ -74.28M$ -64.70M$ -3.52K$ -43.36K
Net Income
$ -134.04M$ -74.28M$ -64.70M$ -3.52K$ -43.36K
Per Share Metrics
Basic EPS
$ -4.30$ 0.46$ >-0.01$ <0.01$ 0.00
Diluted EPS
$ -4.30$ 0.46$ >-0.01$ >-0.01$ 0.00
Weighted Average Shares Outstanding
31.14M 16.64M 20.48M 20.48M 20.48M
Weighted Average Shares Outstanding (Diluted)
31.14M 16.64M 20.48M 20.48M 20.48M
Currency in USD

BridgeBio Oncology Therapeutics Earnings and Revenue History